FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/10/2023
Voltar para busca
Dado oficial do USPTO
(A)
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
10/10/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 9, 10, 42, 44
Data de depósito
14/04/2021
Data de registro
20/06/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/06/2023
Última transação
20/06/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
16
Localização do titular
ES
Examinador
MASON,JARED MICHAEL
Unidade examinadora
N10
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the green stylized wording "(a)".
Titulares e representantes
Titulares
P. S. (pessoa física)
Representantes
Ben Natter Haug Partners, LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the diagnosis and treatment of mental diseases and mental disorders; pharmaceutical preparations for the diagnosis and treatment of neurological diseases; pharmaceutical preparations for the diagnosis and treatment of cerebrovascular diseases; dietary supplements; dietary supplements for the treatment of mental diseasesmental disordersneurological diseases and cerebrovascular diseases
Classe 9
Virtual reality headsets for use in the field of mental health; virtual reality glasses for use in the field of mental health; augmented reality computer hardware for use in the field of mental healthin particular for the diagnosisassessment and treatment of mental illnesses; all the foregoing for use by mental health professionals only
Classe 10
Medical devices for use in the field of mental healthin particular for the diagnosisassessment and treatment of mental illnesses; medical apparatus for use in the field of mental healthin particular for the diagnosisassessment and treatment of mental illnesses; medical devices for the diagnosis and treatment of mental diseases and mental disorders; medical apparatus for the diagnosis and treatment of mental diseases and mental disorders; medical apparatus and devices for the treatment of neurological diseases; medical apparatus and devices for the treatment of cerebrovascular diseases; tools for medical diagnostics in the field of mental healthmedical apparatus for use in identifying and monitoring somatic responsesgalvanic skin responsesheart rate and respiratory rate for the treatment of behavioral health conditions; precision sensors for medical use in the field of mental healthin particular for monitoringdetecting and measuring sweat responseheart rate variabilitybreathing rateoxygen in blood and brain activity; sensor apparatus for medical use in diagnosis of mental diseases and mental disordersin particular for monitoringdetecting and measuring sweat responseheart rate variabilitybreathing rateoxygen in blood and brain activity
Classe 42
Design and development of computer software for use in the field of mental health; design and development of computer software for the diagnosis and treatment of mental diseases and mental disorders; design and development of virtual reality software for use in the field of mental health; design and development of virtual reality software for the diagnosis and treatment of mental diseases and mental disorders; hosting of platforms on the Internet being hosting websites of othersfor use in the field of mental healthfor the diagnosis and treatment of mental diseases and mental disorders; pharmaceutical products development; design and development of pharmaceutical products for the diagnosis and treatment of mental diseases and mental disorders; scientific research in the field of mental health; all the foregoing for use by mental health professionals only
Classe 44
Mental health services; therapy services in the field of mental health; psychological care; psychological treatment; psychological counseling; psychological diagnosis services; psychological testing services; psychological assessment and examination services; preparation of psychological reports being medical diagnostic reporting services; providing information in the field of mental health; providing on-line information in the field of mental health
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
20/09/2023
FIMP
FINAL DISPOSITION PROCESSED
20/09/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20/09/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
20/06/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
20/06/2023
GPNX
NOTIFICATION PROCESSED BY IB
05/04/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/04/2023
PUBO
PUBLISHED FOR OPPOSITION
04/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
15/03/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
15/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/03/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
28/02/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/02/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
28/02/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
28/02/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
28/02/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
28/02/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
23/01/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/01/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/01/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
31/08/2022
GNFR
FINAL REFUSAL E-MAILED
31/08/2022
CNFR
FINAL REFUSAL WRITTEN
31/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/06/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/06/2022
RFNT
REFUSAL PROCESSED BY IB
30/01/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/01/2022
RFRR
REFUSAL PROCESSED BY MPU
07/01/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/12/2021
CNRT
NON-FINAL ACTION WRITTEN
08/12/2021
DOCK
ASSIGNED TO EXAMINER
07/12/2021
MAFR
APPLICATION FILING RECEIPT MAILED
07/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/08/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
29/07/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace (A) ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.